Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Industry Size (2026) USD 2.9 Bn Forecast (2036) USD 7.8 Bn CAGR (2026 to 2036) 11.7% GLP-1 Receptor Agonist Market Size, Market Forecast and Outlook By FMI The GLP-1 receptor agonist market is expected to expand from USD 2.9 billion in 2026 to USD 7.8 billion by 2036
doi: 10.1093/nutrit/nuac109
Key Benefits of BPC-157 Supports tissue repair studied for its potential role in healing muscles, tendons, and ligaments
In human skin fibroblasts, Nrf2-driven antioxidant enzyme expression translated into: Reduced intracellular ROS Improved mitochondrial membrane potential Protection against senescence-associated cell damage [36] In human gingival and periodontal stem cells, Epitalon significantly reduced aging biomarkers such as p16 and p21, decreased ROS levels, and preserved mitochondrial function, even under stress [42]
US$ 20.59
US$ 21.03
US$ 25.02
US$ 25.82
US$ 23.56
US$ 26.41
US$ 26.31
US$ 21.37
US$ 29.16
